
Renibus Therapeutics
Operator of a biotechnology company intended to develop novel pharmacologic therapies. The company develops novel therapeutics for post-operative surgery complications as well as acute and chronic kid...
Valuation
$269M
Latest known
Share Price
N/A
Total Raised
$175.5M
Last Round
N/A